Aubagio

Teriflunomide, sold under the brand name Aubagio, is the active metabolite of leflunomide.[2] Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010.[3] 2-year results were positive.[4] However, the subsequent TENERE head-to-head comparison trial reported that "although permanent discontinuations [of therapy] were substantially less common among M... [wikipedia]